Cumberland Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.124; its P/E ratio is -15.17; Cumberland Pharmaceuticals is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 10.89M	$ 9.22M	$ 9.12M	$ 11.41M	$ 10.30M
Gross Profit	$ 9.37M	$ 7.97M	$ 6.47M	$ 9.19M	$ 8.27M
EBIT	$ 1.06M	$ 365.58K	$ -2.28M	$ -266.99K	$ -1.22M
EBITDA	$ 2.27M	$ 1.63M	$ -1.82M	$ 1.28M	$ 398.20K
Net Income Common Stockholders	$ 872.20K	$ 145.12K	$ -3.41M	$ -408.64K	$ -1.34M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 18.25M	$ 16.39M	$ 19.76M	$ 19.54M	$ 18.22M
Total Assets	$ 89.38M	$ 89.47M	$ 92.93M	$ 90.78M	$ 92.52M
Total Debt	$ 18.95M	$ 20.78M	$ 20.96M	$ 17.93M	$ 19.51M
Net Debt	$ 696.92K	$ 4.39M	$ 1.20M	$ -1.61M	$ 1.30M
Total Liabilities	$ 52.54M	$ 53.42M	$ 56.95M	$ 52.29M	$ 53.31M
Stockholders Equity	$ 37.16M	$ 36.36M	$ 36.27M	$ 38.76M	$ 39.46M
Cash Flow	-
Free Cash Flow	$ 5.30M	$ -1.28M	$ 2.00M	$ 2.42M	$ 2.16M
Operating Cash Flow	$ 5.40M	$ -1.10M	$ 3.64M	$ 2.64M	$ 2.33M
Investing Cash Flow	$ -305.78K	$ -442.09K	$ -640.77K	$ 680.80K	$ -172.59K
Financing Cash Flow	$ -3.28M	$ -1.78M	$ -2.78M	$ -1.99M	$ -1.21M

Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Income Statement >

Cumberland Pharmaceuticals Debt to Assets

Balance Sheet >

Cumberland Pharmaceuticals Cash Flow

Cash Flow >

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing